Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma
Chemotherapy · 2024
DOI: 10.1159/000534470 ↗Kurz gefasst
Fallbericht in der Zeitschrift Chemotherapy, 2024. Verfasst von Hiroki Okumura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan, pbuu59vj@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Anilides, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Vascular endothelial growth factor receptor tyrosine kinase inhibitors are known to cause perforation as one of their severe side effects, and postoperative and postradiation therapy are known risk factors. However, there are few studies on perforation following tumor shrinkage. A 78-year-old woman with postoperative recurring left collecting duct carcinoma of the right hilar lymph nodes and mediastinum underwent eight courses of nivolumab plus cabozantinib, resulting in tumor shrinkage. Three days after the last administration, she developed fever and cough and was hospitalized for right lobar pneumonia. The patient received long-term antibiotics for bronchial fistula with the destruction of the bronchial wall and secondary lung abscess. When using nivolumab plus cabozantinib combination therapy for a tumor with bronchial invasion, physicians should be aware of bronchial perforation as the tumor shrinks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan, pbuu59vj@gmail.com.
- Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
- Department of Urology, Toranomon Hospital, Tokyo, Japan.
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
Zitieren
APA
Okumura, H., Murase, K., Oka, S., Kizawa, R., Yamaguchi, T., Tanabe, Y., Suyama, K., Sakaguchi, K., Urakami, S., & Miura, Y. (2024). Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma. Chemotherapy. https://doi.org/10.1159/000534470
Vancouver
Okumura H, Murase K, Oka S, Kizawa R, Yamaguchi T, Tanabe Y, et al. Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma. Chemotherapy. 2024. doi:10.1159/000534470
BibTeX
@article{Okumura2024,
author = {Okumura, Hiroki and Murase, Kyoko and Oka, Suguru and Kizawa, Rika and Yamaguchi, Takeshi and Tanabe, Yuko and Suyama, Koichi and Sakaguchi, Kazushige and Urakami, Shinji and Miura, Yuji},
title = {Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma},
journal = {Chemotherapy},
year = {2024},
doi = {10.1159/000534470}
}
EUVIMED